Fenoldopam hydrobromide
Fenoldopam hydrobromide structure
|
Common Name | Fenoldopam hydrobromide | ||
|---|---|---|---|---|
| CAS Number | 67287-54-1 | Molecular Weight | 386.66800 | |
| Density | 1.38g/cm3 | Boiling Point | 522.6ºC at 760 mmHg | |
| Molecular Formula | C16H17BrClNO3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 269.9ºC | |
| Symbol |
GHS07, GHS08 |
Signal Word | Danger | |
|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain cancer. However, the complete repertoire of signaling pathways ... |
|
|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Nat. Chem. Biol. 5 , 765-71, (2009) Studies of gene function and molecular mechanisms in Plasmodium falciparum are hampered by difficulties in characterizing and measuring phenotypic differences between individual parasites. We screened seven parasite lines for differences in responses to 1,279... |
|
|
Contrast-induced nephropathy: protective role of fenoldopam.
Clin. Exp. Pharmacol. Physiol. 39(6) , 497-505, (2012) 1. Contrast-induced nephropathy (CIN) often occurs after contrast media-related procedures and is associated with increased morbidity and mortality. The acute renal failure observed after administration of contrast media is usually transient but, in some case... |
|
|
Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
Cardiovasc. Ther. 29(4) , 280-4, (2011) Acute kidney injury is a frequent problem among many critically ill patients, commonly in the context of multiple organ failure and decreased renal perfusion. Its presence conveys a poor prognosis. Currently, effective therapeutic interventions are limited an... |
|
|
Preventable risk factors for acute kidney injury in patients undergoing cardiac surgery.
J. Cardiothorac. Vasc. Anesth. 26(4) , 687-97, (2012)
|
|
|
Effects of fenoldopam mesylate infusion on splanchnic perfusion after myocardial revascularization on cardiopulmonary bypass: an ultrasound Doppler study.
J. Cardiothorac. Vasc. Anesth. 25(4) , 642-6, (2011) To measure the effects of fenoldopam mesylate infusion on splanchnic blood flow in patients undergoing myocardial revascularization with cardiopulmonary bypass.An experimental observational study.A single-institution community hospital.Eighteen patients under... |
|
|
The effect of fenoldopam and dopexamine on cytokine and endotoxin release following on-pump coronary artery bypass grafting: a prospective randomized double-blind trial.
Heart Surg. Forum 13(6) , E353-61, (2010) Surgical trauma, exposure to an external circuit, and reduced organ perfusion contribute to the systemic inflammatory response following cardiopulmonary bypass (CPB). Reduced splanchnic perfusion causes disruption of the gastrointestinal mucosal barrier and t... |
|
|
Editorial comment.
Urology 81(2) , 345-6; discussion 346, (2013)
|
|
|
A novel use for novel acute kidney injury biomarkers: fenoldopam's effect on neutrophil gelatinase-associated lipocalin and cystatin C.
Crit. Care 15(4) , 177, (2011) Substantial basic and translational research has been directed to detect earlier and more sensitive acute kidney injury (AKI) biomarkers over the past decade. Much of the seminal AKI biomarker validation research has been performed in children undergoing card... |
|
|
Balloon test occlusion with hypotensive challenge using a novel agent Fenoldopam: a first experience.
J. Neurosurg. Anesthesiol. 23(3) , 270-1, (2011)
|